46.47
1.71 (3.82%)
1.71 (3.82%)
Upgrade to Real-Time
Afterhours (Closed)
Low
25.49
High
58.47
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Apellis Pharmaceuticals Inc | APLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.71 | 3.82% | 46.47 | 19:30:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 47.70 | 44.615 | 47.92 | 45.57 | 44.76 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 45.57 | 46.49 | 0.92 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,916 | 808,638 | $ 46.28 | $ 37,427,419 | 769,474 | 25.49 - 58.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:21 | 6 | $ 46.49 | USD |
Apellis Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.52B | 75.74M | 49.43M | $ - | $ - | -5.20 | -5.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Apellis Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 41.55 | 47.92 | 40.5311 | 42.71 | 696,260 | 4.92 | 11.84% |
| 1 Month | 43.99 | 47.92 | 39.95 | 42.47 | 722,910 | 2.48 | 5.64% |
| 3 Months | 47.51 | 52.26 | 39.95 | 44.88 | 644,346 | -1.04 | -2.19% |
| 6 Months | 35.48 | 58.47 | 30.14 | 45.95 | 659,534 | 10.99 | 30.98% |
| 1 Year | 31.86 | 58.47 | 25.49 | 38.19 | 706,477 | 14.61 | 45.86% |
| 3 Years | 26.90 | 58.47 | 11.45 | 31.92 | 624,431 | 19.57 | 72.75% |
| 5 Years | 14.50 | 58.47 | 11.45 | 31.46 | 567,035 | 31.97 | 220.48% |
Apellis Pharmaceuticals Description
| Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade. |
